Novel cancer therapeutics with allosteric modulation of the mitochondrial c-raf/dapk complex by raf inhibitor combination therapy

Higher expression of acetyl-tubulin may induce docetaxel resistance in prostate cancer cells

SULF1 overexpression is a poor prognostic factor in patients with urothelial carcinoma

Chemokine CXCL14 (BRAK) expression and potential role in human renal cell carcinoma

Identifying long non-coding RNAs involved in prostate cancer relapse: Implication in identifying novel prognosis markers

Genetic variations in glutathione pathway genes predict cancer recurrence in patients treated with trans-urethral resection and bacillus calmette-guerin instillation for non-muscle invasive bladder cancer

Interaction and function of urothelium and chitosan/collagen tubular scaffold

Neuroprotective effects of exendin-4in brain and bladder of ischemia-reperfusion injury

Closing Remarks